Skip to content

Effect and comparison of general anesthesia with Ciprofol and propofol on anesthesia effect and quality of postoperative recovery in transurethral ureteroscopic lithotripsy surgery

Effect and comparison of general anesthesia with Ciprofol and propofol on anesthesia effects and quality of postoperative recovery in transurethral ureteroscopic lithotripsy: a randomized controlled clinical trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082736
Enrollment
Unknown
Registered
2024-04-07
Start date
2024-04-08
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary tract stone

Interventions

Ciprofol group:General anesthesia was induced with Ciprofol 0.2-0.4 mg/kg intravenously. Anesthesia was maintained with Ciprofol 0.8-1.5 mg/kg/h
Propofol group:In the propofol group, propofol 2-3mg/kg was used for induction of general anesthesia, and propofol 4-10mg/kg/h was used for maintenance of anesthesia.

Sponsors

Lishui People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Elective surgery, inpatients requiring ureteroscopy under general anesthesia tracheal intubation; 2. Male or female, age = 18 years and = 80 years; 3. American Society of Anesthesiologists (ASA) class I-III; 4. Body mass index (BMI) =18 and =30 kg/m2; 5. Vital signs during screening meet the following criteria: a) respiratory rate =10 and =24 breaths/min; b) arterial oxygen saturation (SpO2) =95% during respiration; c) systolic blood pressure =90 mmHg and =160 mmHg; d) diastolic blood pressure =60 mmHg and =100 mmHg; and e) heart rate =55 and =100 bpm.

Exclusion criteria

Exclusion criteria: 1. Pregnant or breastfeeding women and women who plan to give birth within 3 months (including male patients); 2. Obvious respiratory or circulatory dysfunction before surgery, obvious abnormalities in blood routine and biochemical indexes, and serious neuropsychiatric disorders; 3. Use of benzodiazepines or opioids within 1 month, contraindications or allergic reactions to benzodiazepines, opioids, propofol and its components; 4. Those estimated to be difficult to intubate; 5. Patients who, in the judgment of the investigator, are not suitable for participation in this trial for any reason.

Design outcomes

Primary

MeasureTime frame
QoR-15 score;

Secondary

MeasureTime frame
MAP;The time it takes for consciousness to disappear;BIS value at loss of consciousness;Dose of medication required for loss of consciousness;Time to BIS 60;Drug dose required to BIS 60;Intraoperative vasoactive drug use;Lowest blood pressure after induction with ciprofol or propofol;Minimum intraoperative blood pressure and heart rate;Parameters related to surgical anesthesia;Lowest Heart Rate after induction with ciprofol or propofol;Minimum intraoperative heart rate;Time of discharging from bed;Patient Satisfaction Score;Urinary tract symptoms (urinary frequency, urgency, painful urination);Cumulative dose of propofol or cipofol administered;Cumulative dose of sufentanil;Cumulative dose of cisatracurium;Autonomous breathing recovery time;Recovery of consciousness time;Consciousness restoration BIS value;Tracheal tube extubation time;Recovery time inPACU;Recovery Phase RASS Scores;Total length of hospital stay;

Countries

China

Contacts

Public ContactFaxing Wang

Lishui People's Hospital

faxingwanglive@163.com+86 189 5709 2002

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026